Kelly Fenner

Kelly brings 14 years of industry experience from both Wyeth and Pfizer. She began her career as a Medical Technologist for 5 years before moving into the pharmaceutical industry with Wyeth Research. Kelly has data management, GCP compliance and training, regulatory inspection, and quality oversight expertise. Kelly currently works at Pfizer in the Portfolio Quality and Risk Management group. This is a newly formed arm of Pfizer’s GCP Quality Management System. In this position, Kelly supports programs and drives effective management of risks to GCP quality across Pfizer’s clinical portfolio by shifting the focus from reactive error detection and remediation to preventing critical to quality risks from occurring in the first place.